David Lyle - 15 Sep 2023 Form 4 Insider Report for SURGALIGN HOLDINGS, INC.

Reporting relationship: Chief Financial Officer
Issuer ticker: N/A
Reported as of: 15 Sep 2023
Net transaction value: -$13.29
SEC form: 4
Accepted by SEC: 18 Sep 2023, 11:47:26 UTC
Prior SEC filing: 16 Aug 2023
Next SEC filing: 04 Jan 2024
Source filing: View source filing
Reporting owner signature: By Jessica Rumschlag as attorney in fact

Key filing fact

David Lyle filed Form 4 for SURGALIGN HOLDINGS, INC. on 18 Sep 2023.

Key facts

This page summarizes David Lyle's Form 4 filing for SURGALIGN HOLDINGS, INC..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Sep 2023, 11:47.

Change

Previous filing in this sequence was filed on 16 Aug 2023.
Current net transaction value: -$13.29.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRGA transaction

Common Stock

Tax liability

Transaction value: $13.29
Shares: -1,329
Change %: -1.6%
Price: $0.0100^*
Shares after: 83,307
Date: 15 Sep 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld by Surgalign Holdings, Inc. to satisfy the withholding obligation in connection with the vesting of previously awarded restricted stock.